Nasdaq18d
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of ... eRapa is a proprietary oral tablet formulation of rapamycin, also known as sirolimus.
Morningstar18d
Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP
MTX110 is a solubilized formulation of the histone deacetylase (HDAC) inhibitor, panobinostat. This proprietary formulation enables delivery of the product via convection-enhanced delivery (CED ...